Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given written consent to participate
- Women between 18 and 75 years old
- People who have been diagnosed with breast cancer confirmed by a tissue test, and who have had a full surgical removal of the breast (radical mastectomy)
- People whose breast cancer has spread in a limited way (called oligometastasis) to the upper arm bone (humerus) or breastbone (sternum) on the same side as the original cancer, with no imaging evidence of cancer spread anywhere else
- People who have recovered well from side effects of any previous treatments, with only mild or no lingering effects
- People whose HIV test result from a central laboratory is negative before entering the trial
- People whose liver function blood test results (ALT, AST, alkaline phosphatase, GGT, and bilirubin) are within acceptable ranges before the trial begins
- People whose blood protein (albumin) level is at or above a minimum acceptable level
- People whose kidney function blood test (creatinine) is within an acceptable range
- People whose blood count results — including white blood cells, neutrophils, platelets, and haemoglobin — are all within acceptable minimum ranges
- People who are reasonably physically active and able to carry out daily activities, as measured by a standard medical scoring system (ECOG score of 0 to 2)
- Women who could become pregnant and who are using effective contraception
Who may not be able to join:
- People who have not had a full surgical removal of the primary breast tumour
- People whose spread of cancer cannot be treated with surgery or radiotherapy
- People whose cancer has spread to any site other than the upper arm bone or breastbone on the same side as the original cancer
- People who have more than one area where the cancer has spread
- People who have, or have had within the past five years, another type of cancer (with some exceptions for very early-stage cancers such as early cervical carcinoma in situ, skin basal cell carcinoma, or early-stage papillary thyroid carcinoma — confirm with trial site)
- People with an active HIV infection at the time of starting the trial
- People who have taken part in another clinical trial within the 30 days before joining this trial
- People who are known to be unable to tolerate surgery on the humerus or sternum, or unable to tolerate radical radiotherapy
- People who are pregnant or breastfeeding
- People with a serious ongoing illness, such as a significant heart, lung, or kidney condition
- People who are not legally able to make decisions for themselves
- People who, in the opinion of the trial investigator, may not be able to complete the study or sign the consent form due to a medical or mental health condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaobo Yan, MD, The Second Affiliated Hospital of Zhejiang University School of Medicidne
Phone: +86-18329139569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.